Showing results (1811-1820 of 2,540) with videos related to
Sort By:
Pageof 254
Molecular Cell|February 3, 2015
Human promoters are intrinsically directionalSascha H C Duttke, Scott A Lacadie, Mahmoud M Ibrahim, et al.The Knee|August 7, 2024
Mid-term outcomes of acute and delayed total knee arthroplasty following tibial plateau fractures: A matched cohort studyMees K Hesmerg, Joyce L Benner, Lex D de Jong, et al.Advanced Biosystems|May 19, 2020
Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the MicroenvironmentVasudha C Shukla, Silvia Duarte-Sanmiguel, Ana Panic, et al.British Journal of Haematology|August 26, 2004
Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myelomaMarleen H C Bakkus, Yasmina Bouko, Diana Samson, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2011
Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patientsNazanin Noori, Ramanath Dukkipati, Csaba P Kovesdy, et al.Neurotoxicology and Teratology|November 4, 2015
Developmental origin of abnormal dendritic growth in the mouse brain induced by in utero disruption of aryl hydrocarbon receptor signalingEiki Kimura, Ken-Ichiro Kubo, Chieri Matsuyoshi, et al.Frontiers in Immunology|April 25, 2022
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort StudyFelix Korell, Olaf Penack, Mike Mattie, et al.Proceedings of the National Academy of Sciences of the United States of America|September 13, 2018
Deconvolution of pro- and antiviral genomic responses in Zika virus-infected and bystander macrophagesAaron F Carlin, Edward A Vizcarra, Emilie Branche, et al.Nucleic Acids Research|May 26, 2018
Nucleoside analogs to manage sequence divergence in nucleic acid amplification and SNP detectionZunyi Yang, Hyo-Joong Kim, Jennifer T Le, et al.Blood|April 9, 2010
Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvementSascha Dietrich, Stefan O Schönland, Axel Benner, et al.Pageof 254